Cargando…

The Value of Annual Glaucoma Screening for High-Risk Adults Ages 60 to 80

Glaucoma will increase in significance as a public health problem over the next three decades as the size of the aging US population grows more significant. Because glaucoma is more prevalent among African-Americans and Hispanics, and these groups will soon outnumber Caucasians. Therefore, it is eve...

Descripción completa

Detalles Bibliográficos
Autores principales: Allison, Karen, Patel, Deepkumar, Besharim, Caren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582616/
https://www.ncbi.nlm.nih.gov/pubmed/34790465
http://dx.doi.org/10.7759/cureus.18710
_version_ 1784597028057120768
author Allison, Karen
Patel, Deepkumar
Besharim, Caren
author_facet Allison, Karen
Patel, Deepkumar
Besharim, Caren
author_sort Allison, Karen
collection PubMed
description Glaucoma will increase in significance as a public health problem over the next three decades as the size of the aging US population grows more significant. Because glaucoma is more prevalent among African-Americans and Hispanics, and these groups will soon outnumber Caucasians. Therefore, it is even more imperative that a referral for screening protocol for high-risk groups be implemented as the standard of care. At least half of those with glaucoma do not know they have it, and the impact on the quality of life for those whose glaucoma progresses to visual impairment or blindness is significant. Without screening, glaucoma is likely to burden many families, particularly the underserved and society, unduly. Education for the public, those at increased risk, and their physicians about glaucoma, the importance of objective screening, and early treatment even for those with no symptoms will be critical toward the success of any screening protocol.
format Online
Article
Text
id pubmed-8582616
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-85826162021-11-16 The Value of Annual Glaucoma Screening for High-Risk Adults Ages 60 to 80 Allison, Karen Patel, Deepkumar Besharim, Caren Cureus Internal Medicine Glaucoma will increase in significance as a public health problem over the next three decades as the size of the aging US population grows more significant. Because glaucoma is more prevalent among African-Americans and Hispanics, and these groups will soon outnumber Caucasians. Therefore, it is even more imperative that a referral for screening protocol for high-risk groups be implemented as the standard of care. At least half of those with glaucoma do not know they have it, and the impact on the quality of life for those whose glaucoma progresses to visual impairment or blindness is significant. Without screening, glaucoma is likely to burden many families, particularly the underserved and society, unduly. Education for the public, those at increased risk, and their physicians about glaucoma, the importance of objective screening, and early treatment even for those with no symptoms will be critical toward the success of any screening protocol. Cureus 2021-10-12 /pmc/articles/PMC8582616/ /pubmed/34790465 http://dx.doi.org/10.7759/cureus.18710 Text en Copyright © 2021, Allison et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Allison, Karen
Patel, Deepkumar
Besharim, Caren
The Value of Annual Glaucoma Screening for High-Risk Adults Ages 60 to 80
title The Value of Annual Glaucoma Screening for High-Risk Adults Ages 60 to 80
title_full The Value of Annual Glaucoma Screening for High-Risk Adults Ages 60 to 80
title_fullStr The Value of Annual Glaucoma Screening for High-Risk Adults Ages 60 to 80
title_full_unstemmed The Value of Annual Glaucoma Screening for High-Risk Adults Ages 60 to 80
title_short The Value of Annual Glaucoma Screening for High-Risk Adults Ages 60 to 80
title_sort value of annual glaucoma screening for high-risk adults ages 60 to 80
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582616/
https://www.ncbi.nlm.nih.gov/pubmed/34790465
http://dx.doi.org/10.7759/cureus.18710
work_keys_str_mv AT allisonkaren thevalueofannualglaucomascreeningforhighriskadultsages60to80
AT pateldeepkumar thevalueofannualglaucomascreeningforhighriskadultsages60to80
AT besharimcaren thevalueofannualglaucomascreeningforhighriskadultsages60to80
AT allisonkaren valueofannualglaucomascreeningforhighriskadultsages60to80
AT pateldeepkumar valueofannualglaucomascreeningforhighriskadultsages60to80
AT besharimcaren valueofannualglaucomascreeningforhighriskadultsages60to80